health news arrowHome >> *Mental Illness >> Addictions & Dependencies >> Researchers: Flu Vaccine Supply Can Be Stretched Sun, 06 Jul 2008 GMT 
health news
  NEWS YOU CAN TRUST

Search Health News 
Browser Preferences
 Add to Favorites

Main Menu
 Home
 - - - - - Hot Topics - - - - -
 Bird Flu
 Drug Safety
 Stem Cell Research
 - - - - - - - - - - - - - - - - -
 Alternative Medicine
 Children's Health
 Diet & Nutrition
 Disabilities
 *Diseases & Conditions
 Drugs & Herbs
 Environmental Health
 Fitness & Exercise
 Genetic Research
 Health Insurance
 Medical Ethics
 Men's Health
 *Mental Illness
 Addictions & Dependencies
 Bipolar Disor
 Depression
 Schizophrenia
 Pain
 Parenting
 Public Health & Safety
 Senior Care
 *Sexual Health
 Women's Health
 World Health
 - - - - - - - - - - - - - - - -
 Web Links
 Contact Us: info@dailynewscentral.com

XML News Feeds


 

HEALTH NEWS

Researchers: Flu Vaccine Supply Can Be Stretched

PDF  Print  E-mail
Contributed by Ron Gara|  04 November, 2004  06:17 GMT

flu vaccine supply
The short supply of influenza vaccine in the U.S. has led some researchers to look for innovative ways to protect the public. There is at least one way to potentially double the supply of available vaccine for adults between the ages of 18 and 60, according to a study that appears this week in the New England Journal of Medicine.

When it comes to flu vaccinations, the conventional “one size fits all” approach for adults is coming under question, according to lead researcher Robert Belshe, M.D., director of the Center for Vaccine Development at Saint Louis University.

Help for Lower-Risk Groups

“We found that we can give lower doses of vaccine -- 40 percent of the full dose -- if we gave the vaccine not as a shot into the muscle, but ‘intradermally’ between the layers of the skin,” Belshe said. “This lower-dose intradermal vaccine worked well in adults 18 to 60 years of age.”

Intradermal vaccination is an injection between the layers of the skin using a tiny needle, such as what is used for a tuberculosis skin test. Administration of the vaccine in this way involves injecting a small bleb of vaccine into the skin, much like a mosquito bite or allergy skin test, using a very small needle.

Belshe said the lower-dose intradermal vaccine did not, however, work as well in an older population.

Vigorous in Younger Persons

A total of 238 volunteers at Saint Louis University and the University of Rochester were enrolled in the study. This included 130 people between 18-60 and 108 older than 60. Some people received a currently licensed influenza shot in the traditional way -- full dose, using a shot directly into the muscle. A second group received an investigational vaccine by GlaxoSmithKline Biologicals intradermally and with a dose that was 40 percent of the standard dose.

When compared with the full dose of vaccine given as the traditional shot, antibody responses to a lower dose vaccine given under the skin were as vigorous in younger persons but not in people older than 60 years, Belshe said.

One Size Fits Many

“We are learning that the same size dose doesn’t seem to fit all ages,” Belshe noted. “Younger people may need less vaccine, and older people may need more vaccine.”

The nation’s vaccine supply for younger healthy persons conceivably could be stretched 2.5 times using the scheme published in this study. People in this age group for whom the CDC recommends vaccinations (even with this year’s shortages) include health care workers and all people who have contact with babies under 6 months.

The publication of the research was put on a fast track by the New England Journal of Medicine following this fall’s serious influenza vaccine shortages. Among the other study findings:

  • There was significantly less pain with intradermal administration versus the traditional “intramuscular” shot.

  • There was more inflammation at the injection site using the intradermal approach. Belshe said this could be a good thing -- more redness and swelling probably means that the vaccine is doing its job in producing an antibody response.

  • “More and larger studies are needed to confirm these options so that agencies such as the CDC can make recommendations to physicians,” Belshe said.
    • Related Articles
      Lethal Injection Unnecessarily Cruel, Say Researchers (14 Apr 2005)
      testing (2 Oct 2004)
      Weekly Injection Plus Counseling Helps Alcoholics Cut Back (6 Apr 2005)
      New Blood Test Could Detect Ovarian Cancer (10 May 2005)
      U.S. Awaits Test Results on Possible Second Case of Mad Cow Disease (19 Nov 2004)
      US May Okay HIV Test for At-Home Use (14 Oct 2005)
       
      Sponsored Text Links
      SkinStore.com: StriVectin-SD
      InsureMe.com: Click here to get a free health insurance quote.
      SkinStore.com: Strivectin SD 6oz Best Price Offer
      Hydroderm: Lose wrinkles with Hydroderm
      Hydroderm: Body Shape - Proven to be safe and effective - Free Trial!